1. Academic Validation
  2. Design, synthesis and biological evaluation of novel quinazoline derivatives as immune checkpoint inhibitors

Design, synthesis and biological evaluation of novel quinazoline derivatives as immune checkpoint inhibitors

  • Bioorg Med Chem Lett. 2024 Aug 1:108:129796. doi: 10.1016/j.bmcl.2024.129796.
Tam Thuy Lu Vo 1 Van-Hai Hoang 2 Phan Thi Phuong Dung 3 Nguyen Anh Chi 3 Vu Minh Huy 3 Son Tung Ngo 4 Yen Thi Kim Nguyen 5 Tran Thi Thu Hien 6 Tham H Hoang 7 Yen Thi Do 8 Ji Hae Seo 9 Phuong-Thao Tran 10
Affiliations

Affiliations

  • 1 Department of Biochemistry, Keimyung University School of Medicine, Daegu 42601, South Korea; Faculty of Pharmacy and Nursing, Tay Do University, 68 Lo Hau Thanh My, Can Tho 900000, Viet Nam.
  • 2 Faculty of Pharmacy, PHENIKAA University, Hanoi 12116, Viet Nam; PHENIKAA Institute for Advanced Study (PIAS), PHENIKAA University, Yen Nghia, Hadong, Hanoi 12116, Viet Nam.
  • 3 Hanoi University of Pharmacy, 13-15 Le Thanh Tong, Hanoi 100000, Viet Nam.
  • 4 Laboratory of Biophysics, Institute for Advanced Study in Technology, Ton Duc Thang University, Ho Chi Minh City 72915, Viet Nam; Faculty of Pharmacy, Ton Duc Thang University, Ho Chi Minh City 72915, Viet Nam.
  • 5 Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 08826, South Korea.
  • 6 Vietnam University of Traditional Medicine, 2 Tran Phu, Ha Dong, Hanoi 100000, Viet Nam.
  • 7 Center for Biomedical Informatics, Vingroup Big Data Institute, 458 Minh Khai Street, Hai Ba Trung, Hanoi 100000, Viet Nam.
  • 8 Department of Biochemistry, Keimyung University School of Medicine, Daegu 42601, South Korea.
  • 9 Department of Biochemistry, Keimyung University School of Medicine, Daegu 42601, South Korea. Electronic address: seoJh@kmu.ac.kr.
  • 10 Hanoi University of Pharmacy, 13-15 Le Thanh Tong, Hanoi 100000, Viet Nam. Electronic address: thaotp@hup.edu.vn.
Abstract

In this work, we report 14 novel quinazoline derivatives as Immune Checkpoint inhibitors, IDO1 and PD-L1. The antitumor screening of synthesized compounds on ovarian Cancer cells indicated that compound V-d and V-l showed the most activity with IC50 values of about 5 μM. Intriguingly, compound V-d emerges as a stand out, triggering cell death through caspase-dependent and caspase-independent manners. More importantly, V-d presents its ability to hinder tumor sphere formation and re-sensitized cisplatin-resistant A2780 cells to cisplatin treatment. These findings suggest that compound V-d emerges as a promising lead candidate for the future development of immuno Anticancer agents.

Keywords

Immune check point; Indoleamine 2,3-dioxygenase 1; Ovarian cancer; Quinazoline.

Figures
Products